Regeneron Pharmaceuticals, Inc., Bayer HealthCare Say Eye Drug Meets Mid-stage Goal

Reuters -- Regeneron Pharmaceuticals and Bayer HealthCare, a U.S. unit of Germany's Bayer, said their experimental drug to treat retinal swelling brought on by diabetes, met its primary goal in a mid-stage study.